文献速递哮喘

U-BIOPRED重度哮喘痰分子表型的不稳定性

Instability of sputum molecular phenotypes in U-BIOPRED severe asthma.
PubMed 文献 · Eur Respir J · 2021-02-04

该研究基于U-BIOPRED项目,对重度哮喘患者痰转录组进行聚类分析获得三个转录相关簇(TAC),1年后45%患者分子表型发生改变,并伴随痰粒细胞标志物变化,提示不稳定组驱动机制存在变异性。

要点

  • 重度哮喘痰分子表型(TAC)在1年内有45%患者发生改变
  • 表型改变伴随痰粒细胞标志物的同步变化
  • 提示不稳定组哮喘驱动机制存在变异性

核心结论

  • 重度哮喘患者痰分子表型在1年内有45%发生改变,提示驱动机制的不稳定性。

研究设计与样本

  • 基于U-BIOPRED项目,采用系统生物学方法对重度哮喘患者痰转录组进行层次聚类分析。

主要发现

  • 共获得三个转录相关簇(TAC1、TAC2、TAC3),分别对应T2炎症伴痰嗜酸粒细胞增多、炎症小体及IFN-α/TNF-α相关基因伴痰中性粒细胞增多、代谢和线粒体功能基因伴寡粒细胞炎症。
  • 1年后45%的重度哮喘患者痰分子表型发生改变,并伴随痰粒细胞标志物的同步变化。

关键数值与推荐

  • TAC1特征为IL33R、CCR3、TSLPR受体及IL-13/2型炎症基因特征富集,伴痰嗜酸粒细胞增多。
  • TAC2特征为炎症小体相关基因、IFN-α和TNF-α相关基因,伴痰中性粒细胞增多。
  • TAC3特征为代谢和线粒体功能基因,伴寡粒细胞炎症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

At 1 year, 45% of severe asthma change molecular phenotype as determined by sputum transcriptomic analysis. Together with concomitant shift in sputum granulocytic markers, this may indicate variability of driving mechanisms in this unstable group. https://bit.ly/35aj489 The Unbiased Biomarkers for the Prediction of Respiratory Disease Outcomes (U-BIOPRED) project has described phenotypic differences of severe asthma using a systems biology approach. We obtained three molecular phenotypes termed transcription-associated clusters (TACs) using hierarchical clustering of differentially expressed transcripts between T2-high and T2-low [1]. TAC1 was characterised by receptors IL33R, CCR3 and TSLPR, with the highest enrichment of gene signatures for IL-13/type-2 (T2) inflammation with sputum eosinophilia; TAC2 by inflammasome-associated genes, interferon-α (IFN-α) and tumour necrosis factor-α (TNF-α)-associated genes with sputum neutrophilia; and TAC3 by metabolic and mitochondrial function genes with pauci-granulocytic inflammation. Given that sputum eosinophilia may vary with time in many asthmatic subjects [2, 3], we hypothesised that TAC status may also change with time.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Kermani NZ, Pavlidis S, Xie J, et al. Instability of sputum molecular phenotypes in U-BIOPRED severe asthma. Eur Respir J. 2021. PMID: 33008937. doi:10.1183/13993003.01836-2020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。